Analyst Josh Jennings of TD Cowen reiterated a Buy rating on Establishment Labs Holdings (ESTA – Research Report), retaining the price target of $75.00.
Josh Jennings has given his Buy rating due to a combination of factors that highlight Establishment Labs Holdings’ promising growth prospects. The company’s recent quarterly results and guidance for 2025 align with previous expectations, showcasing a strong foundation for future performance. A key driver of this optimism is the successful launch of Motiva in the US, which represents a significant growth opportunity for the company.
Jennings notes the encouraging early commercial trends for Motiva, with an increasing number of active surgeon accounts and a high reorder rate, indicating strong market acceptance. The company’s strategic focus on expanding its presence among US-based plastic surgeons is supported by a well-established sales team, ensuring broad market coverage. With the current trajectory of order growth, Establishment Labs Holdings is well-positioned to meet its revenue targets, reinforcing Jennings’s confidence in the stock’s potential.
In another report released yesterday, BTIG also reiterated a Buy rating on the stock with a $62.00 price target.
Based on the recent corporate insider activity of 37 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of ESTA in relation to earlier this year.